Cipro
NDC Package 0085-1773-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Cipro is a medication used to treat a variety of bacterial infections. Marketed by Schering Plough Corporation, this product is identified by NDC 0085-1773 and is authorized under FDA application NDA020780.

Identification & Billing

NDC Package Code
0085-1773-01
Package Description
1 KIT in 1 KIT * 100 mL in 1 BOTTLE, GLASS * 100 mL in 1 BOTTLE, GLASS
Product Code
11-Digit Billing Format
00085177301

Clinical Specifications

Proprietary Name
Cipro
Dosage Form
-
Usage Information
This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Schering Plough Corporation
FDA Application #
NDA020780
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-27-2009
End Marketing Date
07-01-2013
Listing Expiration
07-01-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0085-1773-01 identifies a specific commercial package of 1 kit in 1 kit * 100 ml in 1 bottle, glass * 100 ml in 1 bottle, glass of Cipro, labeled by Schering Plough Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Schering Plough Corporation on April 27, 2009. The current certification is valid through July 01, 2013.

What are the primary indications for this medication?

This medication is used to treat a variety of bacterial infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Schering Plough Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00085177301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0085-1773-01
11-Digit CMS (5-4-2)
00085-1773-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.